Bilcare Limited

Healthcare · Healthcare Services

NSE: BI BSE: 526853
₹98.67
▼ -2.01 (-2.00%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
34/100
Weak
Valuation
57/100
Fairly Valued
Momentum
27/100
Bearish

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹232 Cr
PE (TTM)
Data unavailable.
Price to Book
3.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
64.1
Relative return vs Sector, qtr %
63.3
Free Cash Flow
₹117 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-71.05%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
73.14%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
-45.45%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
50.56%
as of Dec. 31, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
-6.28%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
0.99
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
8.37
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
-2.48
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
156.65%
as of Dec. 31, 2025
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
53.09%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
-21.43%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
2.35%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
0.50%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
2.54%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (8.37)
  • No Return on equity is 15% or more (2.5%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (1.4% pledged)

Peer comparison

1 of 2 met
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.0%
Low 98.6700 · High 98.6700
1W return
-5.9%
Low 96.7400 · High 103.0000
1M return
8.7%
Low 85.0000 · High 113.0000
52W return
Data unavailable.
Low 51.6200 · High 113.0000
Lifetime High ₹109.1700 (Sept. 21, 2026)
Lifetime Low ₹56.1800 (June 29, 2026)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish2
5D
100.4
10D
100.7
20D
98.0
50D
87.9
100D
75.8

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

98.67
Pivot
First resistance98.67
Second resistance98.67
Third resistance98.67
First support98.67
Second support98.67
Third support98.67
Day RSI54.3
Day MFI72.8
Day MACD4.50
Day MACD signal5.69

Beta

1M1.11
3M0.33
1Y-0.02
3Y-0.02

Price change analysis

↑ 8.7%
Over 1 Month
LowHigh
85.00113.00
↑ 60.5%
Over 3 Months
LowHigh
57.50113.00
—
Over 6 Months
LowHigh
51.62113.00
—
Over 1 Year
LowHigh
51.62113.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹2 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹0.4400

Ranks #39 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter30.01%
  • FII/FPI0.04%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 30.01% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.04% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 6 SAST, 0 pledge events →

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
7 Sep 2026 GUTTIKONDA VARA LAKSHMI Bulk Buy 125,814 100.6400 NSE
19 Aug 2026 GUTTIKONDA VARA LAKSHMI Bulk Sell 192,861 96.9600 NSE
15 Sep 2025 GUTTIKONDA VARA LAKSHMI Bulk Buy 175,344 93.4800 BSE
29 Aug 2025 GUTTIKONDA RAJASEKHAR Bulk Sell 2,756 70.3500 BSE
29 Aug 2025 GUTTIKONDA RAJASEKHAR Bulk Buy 120,368 70.2600 BSE
3 Apr 2025 GUTTIKONDA RAJASEKHAR Bulk Buy 140,931 94.5600 BSE
28 Mar 2025 GUTTIKONDA VARA LAKSHMI Bulk Buy 130,325 92.3000 BSE
25 Mar 2025 GUTTIKONDA VARA LAKSHMI Bulk Buy 139,589 82.6500 BSE
21 Mar 2025 SHAH SHARAD KANAYALAL Bulk Sell 210,254 71.6900 BSE
21 Mar 2025 GUTTIKONDA VARA LAKSHMI Bulk Buy 217,673 72.0700 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from B I Limited to Bilcare Ltd.
—NAME_CHANGEName changed from Bhandari Industries Ltd. to Bilcare Ltd.

All corporate actions →

Corporate Announcements

All 6 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Bilcare Ltd-$ - 526853 - Voting Results Of 39Th Annual General Meeting And Scrutinizers Report
28 Sep 2026 Insider Trading / SAST Bilcare Ltd-$ - 526853 - Closure of Trading Window
21 Sep 2026 Insider Trading / SAST Bilcare Ltd-$ - 526853 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
4 Sep 2026 AGM/EGM Bilcare Ltd-$ - 526853 - Annual Report - 2025-26
4 Sep 2026 Others Bilcare Ltd-$ - 526853 - Board Meeting Outcome for Outcome Of Board Meeting
4 Sep 2026 Others Bilcare Ltd-$ - 526853 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (156.6%)

Weaknesses

  • Low Return on Equity (2.5%)
  • High financial leverage (Debt/Equity 8.37)
  • Tight liquidity (Current Ratio 0.99)
  • Declining revenue YoY (-6.3%)

Opportunities

Data unavailable.

Threats

  • Weak interest coverage (-2.5x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Bilcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.